Cargando…

The lipid accumulation product is a powerful tool to diagnose metabolic dysfunction-associated fatty liver disease in the United States adults

BACKGROUND & OBJECTIVES: Body mass index (BMI) and waist circumference (WC) are widely used to assess obesity, but they are limited in their ability to distinguish complicated body metabolic situations (fat mass, lean body mass, visceral and subcutaneous fat deposits in the abdomen). The purpose...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Hejun, Zhang, Ying, Luo, Hengcong, Lin, Rong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9672518/ https://www.ncbi.nlm.nih.gov/pubmed/36407325 http://dx.doi.org/10.3389/fendo.2022.977625

Ejemplares similares

Association of Metabolic Dysfunction-Associated Fatty Liver Disease and Liver Stiffness With Bone Mineral Density in American Adults
por: Li, Hejun, et al.
Publicado: (2022)

Gut Dysfunction and Non-alcoholic Fatty Liver Disease
por: Grabherr, Felix, et al.
Publicado: (2019)

Lipid accumulation product is a powerful tool to predict non-alcoholic fatty liver disease in Chinese adults
por: Dai, Haijiang, et al.
Publicado: (2017)

Correlation of multiple lipid and lipoprotein ratios with nonalcoholic fatty liver disease in patients with newly diagnosed type 2 diabetic mellitus: A retrospective study
por: Li, Ran, et al.
Publicado: (2023)

Contribution of Liver and Pancreatic Islet Crosstalk to β-Cell Function/Dysfunction in the Presence of Fatty Liver
por: López-Bermudo, Lucía, et al.
Publicado: (2022)

Varied Relationship of Lipid and Lipoprotein Profiles to Liver Fat Content in Phenotypes of Metabolic Associated Fatty Liver Disease
por: Wu, Tingfeng, et al.
Publicado: (2021)

Effects of sitagliptin on intrahepatic lipid content in patients with non-alcoholic fatty liver disease
por: Wang, Xingchun, et al.
Publicado: (2022)

Sequential algorithm to stratify liver fibrosis risk in overweight/obese metabolic dysfunction-associated fatty liver disease
por: Lee, Chi-Ho, et al.
Publicado: (2023)

A Bidirectional Relationship Between Hyperuricemia and Metabolic Dysfunction-Associated Fatty Liver Disease
por: Yang, Chengzhang, et al.
Publicado: (2022)

Metabolic dysfunction-associated fatty liver disease and cardiovascular disease: A meta-analysis
por: Wen, Wen, et al.
Publicado: (2022)

Development and validation of a non-invasive model for predicting significant fibrosis based on patients with nonalcoholic fatty liver disease in the United States
por: Guo, Yuanhui, et al.
Publicado: (2023)

IRX3 plays an important role in the pathogenesis of metabolic-associated fatty liver disease by regulating hepatic lipid metabolism
por: Ma, Yongqiang, et al.
Publicado: (2022)

Androgen dysfunction in non-alcoholic fatty liver disease: Role of sex hormone binding globulin
por: Song, Myeong Jun, et al.
Publicado: (2022)

The nonlinear relationship between thyroid function parameters and metabolic dysfunction-associated fatty liver disease
por: Hu, Yingying, et al.
Publicado: (2023)

The relationship between metabolic dysfunction-associated fatty liver disease and the incidence rate of extrahepatic cancer
por: Wei, Suosu, et al.
Publicado: (2023)

Metabolic dysfunction-associated fatty liver disease increased the risk of subclinical carotid atherosclerosis in China
por: Lei, Fang, et al.
Publicado: (2023)

High-Sensitive CRP Correlates With the Severity of Liver Steatosis and Fibrosis in Obese Patients With Metabolic Dysfunction Associated Fatty Liver Disease
por: Zhu, Cuiling, et al.
Publicado: (2022)

Association of Metabolic Dysfunction-Associated Fatty Liver Disease With Left Ventricular Diastolic Function and Cardiac Morphology
por: Peng, Dandan, et al.
Publicado: (2022)

Sex- and region-specific associations of skeletal muscle mass with metabolic dysfunction-associated fatty liver disease
por: Xiao, Pei, et al.
Publicado: (2022)

Blood lactate levels are associated with an increased risk of metabolic dysfunction-associated fatty liver disease in type 2 diabetes: a real-world study
por: Ma, Yi-Lin, et al.
Publicado: (2023)

Neurovascular coupling unit dysfunction and dementia: Retinal measurements as tools to move towards population-based evidence
por: van der Heide, Frank C. T., et al.
Publicado: (2022)

Advancements in the treatment of non-alcoholic fatty liver disease (NAFLD)
por: Rong, Li, et al.
Publicado: (2023)

Qushi Huayu decoction ameliorates non-alcoholic fatty liver disease in rats by modulating gut microbiota and serum lipids
por: Ni, Yiming, et al.
Publicado: (2023)

Lipid droplet accumulation in β cells in patients with type 2 diabetes is associated with insulin resistance, hyperglycemia and β cell dysfunction involving decreased insulin granules
por: Horii, Tomomi, et al.
Publicado: (2022)

Metabolic dysfunction-associated fatty liver disease is an early predictor for testosterone deficiency in aging men without metabolic syndrome
por: Liu, Chia-Chu, et al.
Publicado: (2023)

Ectopic lipid metabolism in anterior pituitary dysfunction
por: Baumgartner, Clemens, et al.
Publicado: (2023)

Angiotensinogen Gene Silencing Reduces Markers of Lipid Accumulation and Inflammation in Cultured Adipocytes
por: Carroll, Wenting X., et al.
Publicado: (2013)

JunD Regulates Pancreatic β-Cells Function by Altering Lipid Accumulation
por: Wang, Kexin, et al.
Publicado: (2021)

Relative Children’s Lipid Accumulation Product Is a Novel Indicator for Metabolic Syndrome
por: Zhang, Li, et al.
Publicado: (2021)

High liver fibrosis scores in metabolic dysfunction-associated fatty liver disease patients are associated with adverse atrial remodeling and atrial fibrillation recurrence following catheter ablation
por: Decoin, Raphaël, et al.
Publicado: (2022)

The Role of Thyroid Hormones and Autoantibodies in Metabolic Dysfunction Associated Fatty Liver Disease: TgAb May Be a Potential Protective Factor
por: Zhang, Xiaofu, et al.
Publicado: (2020)

Serum iron is closely associated with metabolic dysfunction-associated fatty liver disease in type 2 diabetes: A real-world study
por: Wang, Jun-Wei, et al.
Publicado: (2022)

Emerging trends and hotspots in metabolic dysfunction-associated fatty liver disease (MAFLD) research from 2012 to 2021: A bibliometric analysis
por: Liao, Yudi, et al.
Publicado: (2023)

Hypoxia Induces Saturated Fatty Acids Accumulation and Reduces Unsaturated Fatty Acids Independently of Reverse Tricarboxylic Acid Cycle in L6 Myotubes
por: Vacek, Lukas, et al.
Publicado: (2022)

Understanding gut-liver axis nitrogen metabolism in Fatty Liver Disease
por: Delgado, Teresa C., et al.
Publicado: (2022)

Associations of lipid parameters with non-alcoholic fatty liver disease in type 2 diabetic patients according to obesity status and metabolic goal achievement
por: Zhu, Zengzhe, et al.
Publicado: (2022)

Association and Interaction Between Serum Interleukin-6 Levels and Metabolic Dysfunction-Associated Fatty Liver Disease in Patients With Severe Coronavirus Disease 2019
por: Gao, Feng, et al.
Publicado: (2021)

Editorial: Obesity, Smoking, and Fatty Liver Disease
por: Sinha-Hikim, Amiya P., et al.
Publicado: (2018)

Alternative RNA Splicing in Fatty Liver Disease
por: Wu, Panyisha, et al.
Publicado: (2021)

Endotoxins and Non-Alcoholic Fatty Liver Disease
por: Kessoku, Takaomi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hnqvipe6p2n9v284dmig6qt871